Sildenafil citrate significantly improves nocturnal penile erections in sildenafil non-responding patients with psychogenic erectile dysfunction

Int J Impot Res. 2004 Dec;16(6):552-6. doi: 10.1038/sj.ijir.3901245.

Abstract

Effects of sildenafil citrate on nocturnal penile tumescence and rigidity (NPTR) were evaluated among sildenafil non-responding patients with psychogenic erectile dysfunction. All patients (n=30), equally divided into groups I and II, completed four consecutive nights using the RigiScan Plus device. Sildenafil citrate (50 mg) was given in the third night in group I and in the fourth in group II, whereas a placebo was given in the remaining nights. Additional patients (n=12) receiving only a placebo served as a control group. Results of NPTR recordings revealed neither significant differences between the control and non-sildenafil nights of both test groups, nor between the corresponding values of both groups (P>0.05). On the other hand, when sildenafil citrate nights of groups I and II taken together were compared with placebo nights, a significant increase of total events duration (P<0.001), average rigidity of the tip (P<0.05) and base (P<0.01), and rigidity activity unit (RAU) and tumescence activity unit (TAU) of tip and base (P<0.001) was observed. These results suggest that performance anxiety may be responsible for failure of response during awakening.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Adult
  • Anxiety
  • Circadian Rhythm
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / psychology*
  • Humans
  • Male
  • Middle Aged
  • Penile Erection / drug effects*
  • Piperazines / therapeutic use*
  • Placebos
  • Purines
  • Sildenafil Citrate
  • Sulfones
  • Treatment Failure
  • Wakefulness

Substances

  • Piperazines
  • Placebos
  • Purines
  • Sulfones
  • Sildenafil Citrate